Cargando…

SARS-CoV2 induced respiratory distress: Can cannabinoids be added to anti-viral therapies to reduce lung inflammation?

Detalles Bibliográficos
Autores principales:	Byrareddy, Siddappa N., Mohan, Mahesh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Inc. 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7187842/ https://www.ncbi.nlm.nih.gov/pubmed/32360437 http://dx.doi.org/10.1016/j.bbi.2020.04.079

Ejemplares similares

Drug Repurposing Approaches to Combating Viral Infections
por: Trivedi, Jay, et al.
Publicado: (2020)

Cannabinoid enhancement of lncRNA MMP25-AS1/MMP25 interaction reduces neutrophil infiltration and intestinal epithelial injury in HIV/SIV infection
por: Premadasa, Lakmini S., et al.
Publicado: (2023)

Cannabinoid Attenuation of Intestinal Inflammation in Chronic SIV-Infected Rhesus Macaques Involves T Cell Modulation and Differential Expression of Micro-RNAs and Pro-inflammatory Genes
por: Kumar, Vinay, et al.
Publicado: (2019)

Biomarkers of Activation and Inflammation to Track Disparity in Chronological and Physiological Age of People Living With HIV on Combination Antiretroviral Therapy
por: Thurman, Michellie, et al.
Publicado: (2020)

Cannabinoid control of gingival immune activation in chronically SIV-infected rhesus macaques involves modulation of the indoleamine-2,3-dioxygenase-1 pathway and salivary microbiome
por: McDew-White, Marina, et al.
Publicado: (2021)

Long Term Delta-9-tetrahydrocannabinol Administration Inhibits Proinflammatory Responses in Minor Salivary Glands of Chronically Simian Immunodeficieny Virus Infected Rhesus Macaques
por: Alvarez, Xavier, et al.
Publicado: (2020)

Combining antiviral drugs with BET inhibitors is beneficial in combatting SARS‐CoV‐2 infection
por: Acharya, Arpan, et al.
Publicado: (2022)

SARS-CoV-2 Infection Leads to Neurological Dysfunction
por: Acharya, Arpan, et al.
Publicado: (2020)

Therapeutic Potential of Cannabis: A Comprehensive Review of Current and Future Applications
por: Leinen, Zach J., et al.
Publicado: (2023)

Feasibility of Known RNA Polymerase Inhibitors as Anti-SARS-CoV-2 Drugs
por: Neogi, Ujjwal, et al.
Publicado: (2020)

Omicron SARS-CoV-2 variant: Unique features and their impact on pre-existing antibodies
por: Kannan, Saathvik R., et al.
Publicado: (2022)

Therapeutic implications of SARS-CoV-2 dysregulation of the gut-brain-lung axis
por: Johnson, Samuel D, et al.
Publicado: (2021)

PI3K‐α/mTOR/BRD4 inhibitor alone or in combination with other anti‐virals blocks replication of SARS‐CoV‐2 and its variants of concern including Delta and Omicron
por: Acharya, Arpan, et al.
Publicado: (2022)

Viral Nephropathies, Adding SARS-CoV-2 to the List
por: Pramod, Sheena, et al.
Publicado: (2021)

Immune landscape of female reproductive tract and HIV susceptibility
por: Byrareddy, Siddappa N.
Publicado: (2021)

Peptide Nanoarray Scaffold Vaccine for SARS-COV-2 and Its Variants of Concerns
por: Zagorski, Karen, et al.
Publicado: (2022)

Characterization of multiple interactions between the envelope E protein of SARS-CoV-2 and human BRD4
por: Zandian, Mohamad, et al.
Publicado: (2022)

Modular nanoarray vaccine for SARS-CoV-2
por: Zagorski, Karen, et al.
Publicado: (2022)

Early treatment with anti-α(4)β(7) antibody facilitates increased gut macrophage maturity in SIV-infected rhesus macaques
por: Johnson, Samuel D., et al.
Publicado: (2022)

Discovery and Evaluation of Entry Inhibitors for SARS-CoV-2 and Its Emerging Variants
por: Acharya, Arpan, et al.
Publicado: (2021)

Cannabinoids and Viral Infections
por: Reiss, Carol Shoshkes
Publicado: (2010)

In silico and in vitro studies reveal complement system drives coagulation cascade in SARS-CoV-2 pathogenesis
por: Tiwari, Ritudhwaj, et al.
Publicado: (2020)

Infectivity of SARS-CoV-2: there Is Something More than D614G?
por: Kannan, Saathvik R., et al.
Publicado: (2020)

Cannabinoids Reduce Markers of Inflammation and Fibrosis in Pancreatic Stellate Cells
por: Michalski, Christoph W., et al.
Publicado: (2008)

Rapamycin as a potential repurpose drug candidate for the treatment of COVID-19
por: Husain, Amjad, et al.
Publicado: (2020)

Proteomic landscape of astrocytes and pericytes infected with HIV/SARS-CoV-2 mono/co-infection, impacting on neurological complications
por: Acharya, Arpan, et al.
Publicado: (2023)

Is SARS-CoV-2 viral load a predictor of mortality in COVID-19 acute respiratory distress syndrome patients?
por: Dogan, Lerzan, et al.
Publicado: (2022)

Role of Cannabinoids in Inflammation
por: Downer, Eric J.
Publicado: (2022)

Viral Pneumonia and Acute Respiratory Distress Syndrome
por: Shah, Raj D., et al.
Publicado: (2017)

Evolutionary analysis of the Delta and Delta Plus variants of the SARS-CoV-2 viruses
por: Kannan, Saathvik R., et al.
Publicado: (2021)

Evolution, correlation, structural impact and dynamics of emerging SARS-CoV-2 variants
por: Spratt, Austin N., et al.
Publicado: (2021)

ACE-2, TMPRSS2, and Neuropilin-1 Receptor Expression on Human Brain Astrocytes and Pericytes and SARS-CoV-2 Infection Kinetics
por: Malik, Johid Reza, et al.
Publicado: (2023)

Is there an added value in more real‐world cannabinoids studies?
por: Eisenberg, Elon
Publicado: (2022)

The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak
por: Rothan, Hussin A., et al.
Publicado: (2020)

Lack of viral clearance by the combination of hydroxychloroquine and azithromycin or lopinavir and ritonavir in SARS-CoV-2-related acute respiratory distress syndrome
por: Hraiech, Sami, et al.
Publicado: (2020)

SARS-CoV-2-Infection (COVID-19): Clinical Course, Viral Acute Respiratory Distress Syndrome (ARDS) and Cause(s) of Death
por: Ramadori, Giuliano Pasquale
Publicado: (2022)

Defective viral genomes can protect against SARS-CoV-2 variants and other respiratory viruses
por: Flemming, Alexandra
Publicado: (2021)

Can Some Viral Respiratory Infections Observed Before the Pandemic Announcement Be Related to SARS-CoV-2?
por: Özgen Alpaydın, Aylin, et al.
Publicado: (2023)

Use of Cannabinoids to Treat Acute Respiratory Distress Syndrome and Cytokine Storm Associated with Coronavirus Disease-2019
por: Nagarkatti, Prakash, et al.
Publicado: (2020)

Defibrotide Therapy for Sars CoV2 Acute Respiratory Distress Syndrome
por: Yanik, Gregory A, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_h2gl2jcf354s96hbiidmiah6pj